Clinical trialNCT00895011CompletedPhase 3Interventional

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

SponsorVIVUS LLCEnrollment298Erectile Dysfunction

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Mulhall, MD
Memorial Sloan Kettering Cancer Center
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Phoenix, Arizona, United States
Research Site
Laguna Hills, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Research Site
Sacramento, California, United States
Research Site
Aurora, Colorado, United States
Research Site
Englewood, Colorado, United States
Research Site
Parker, Colorado, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Trinity, Florida, United States
Research Site
Chicago, Illinois, United States
Research Site
Chicago, Illinois, United States
Research Site
Springfield, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Baltimore, Maryland, United States
Research Site
Towson, Maryland, United States
Research Site
Brighton, Massachusetts, United States
Research Site
Burlington, Massachusetts, United States
Research Site
Jamaica Plain, Massachusetts, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Hackensack, New Jersey, United States
Research Site
Lawrenceville, New Jersey, United States
Research Site
Brooklyn, New York, United States
Research Site
Brooklyn, New York, United States
Research Site
Garden City, New York, United States
Research Site
Great Neck, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
New York, New York, United States
Research Site
Poughkeepsie, New York, United States
Research Site
Durham, North Carolina, United States
Research Site
Greensboro, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cleveland, Ohio, United States
Research Site
Bala-Cynwyd, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States

11 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AvanafilPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2009
Primary completion: 30 Apr 2011
Completion: 30 Apr 2011
Last update posted: 1 Oct 2012
Registered enrollment: 298
Registry id: NCT00895011

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.